Home214450 • KOSDAQ
add
PharmaResearch Co Ltd
Nakaraang pagsara
₩563,000.00
Sakop ng araw
₩552,000.00 - ₩584,000.00
Sakop ng taon
₩191,600.00 - ₩713,000.00
Market cap
5.74T KRW
Average na Volume
116.20K
P/E ratio
47.60
Dividend yield
0.20%
Primary exchange
KOSDAQ
Mga balita tungkol sa merkado
Financial Post
1 araw ang nakalipas
With the TSX in 'rarefied territory,' is it time to get defensive?
1.15%
Mga Financial
Income Statement
Kita
Net na kita
| (KRW) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 140.61B | 69.19% |
Gastos sa pagpapatakbo | 51.32B | 80.25% |
Net na kita | 47.40B | 51.05% |
Net profit margin | 33.71 | -10.73% |
Kita sa bawat share | — | — |
EBITDA | 59.82B | 76.44% |
Aktuwal na % ng binabayarang buwis | 24.69% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (KRW) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 481.06B | 133.44% |
Kabuuang asset | 923.24B | 53.50% |
Kabuuang sagutin | 285.11B | 208.67% |
Kabuuang equity | 638.13B | — |
Natitirang share | 10.39M | — |
Presyo para makapag-book | 9.56 | — |
Return on assets | 15.41% | — |
Return on capital | 16.90% | — |
Cash Flow
Net change in cash
| (KRW) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 47.40B | 51.05% |
Cash mula sa mga operasyon | 39.06B | 29.30% |
Cash mula sa pag-invest | -34.44B | 24.73% |
Cash mula sa financing | -12.53B | -12.14% |
Net change in cash | -11.03B | 58.44% |
Malayang cash flow | 11.75B | 256.77% |
Tungkol
CEO
Itinatag
1993
Website
Mga Empleyado
450
